SG11201804184SA - New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 - Google Patents
New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3Info
- Publication number
- SG11201804184SA SG11201804184SA SG11201804184SA SG11201804184SA SG11201804184SA SG 11201804184S A SG11201804184S A SG 11201804184SA SG 11201804184S A SG11201804184S A SG 11201804184SA SG 11201804184S A SG11201804184S A SG 11201804184SA SG 11201804184S A SG11201804184S A SG 11201804184SA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- 4ekdo
- kdo
- ara
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
- C07H7/027—Keto-aldonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15306824.2A EP3170830A1 (en) | 2015-11-17 | 2015-11-17 | New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds ; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 |
PCT/EP2016/077900 WO2017085144A1 (en) | 2015-11-17 | 2016-11-16 | New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201804184SA true SG11201804184SA (en) | 2018-06-28 |
Family
ID=55024958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201804184SA SG11201804184SA (en) | 2015-11-17 | 2016-11-16 | New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 |
Country Status (11)
Country | Link |
---|---|
US (1) | US10717718B2 (zh) |
EP (2) | EP3170830A1 (zh) |
JP (1) | JP6923520B2 (zh) |
KR (1) | KR20180095508A (zh) |
CN (1) | CN108431014B (zh) |
AU (1) | AU2016358039B2 (zh) |
BR (1) | BR112018010056B1 (zh) |
CA (1) | CA3005500A1 (zh) |
SG (1) | SG11201804184SA (zh) |
WO (1) | WO2017085144A1 (zh) |
ZA (1) | ZA201803250B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113677997A (zh) * | 2019-02-20 | 2021-11-19 | 迪亚米德克斯 | 使用修饰的单糖化合物用于标记来自多细胞生物的真核细胞以及用于治疗和/或诊断癌症的方法 |
IL299328A (en) * | 2020-07-07 | 2023-02-01 | Theraonco | Methods for treating cancer using an adapted monosaccharide compound |
WO2024105051A1 (en) * | 2022-11-15 | 2024-05-23 | Ecole Polytechnique Federale De Lausanne (Epfl) | Method for preparing an at least partially acetal-protected sugar |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2617833A1 (en) * | 2012-01-18 | 2013-07-24 | Centre National de la Recherche Scientifique (CNRS) | A method for specifically detecting living bacteria |
-
2015
- 2015-11-17 EP EP15306824.2A patent/EP3170830A1/en not_active Withdrawn
-
2016
- 2016-11-16 CA CA3005500A patent/CA3005500A1/en active Pending
- 2016-11-16 WO PCT/EP2016/077900 patent/WO2017085144A1/en active Application Filing
- 2016-11-16 SG SG11201804184SA patent/SG11201804184SA/en unknown
- 2016-11-16 AU AU2016358039A patent/AU2016358039B2/en active Active
- 2016-11-16 EP EP16801993.3A patent/EP3377507B1/en active Active
- 2016-11-16 US US15/777,060 patent/US10717718B2/en active Active
- 2016-11-16 CN CN201680072705.1A patent/CN108431014B/zh active Active
- 2016-11-16 KR KR1020187014061A patent/KR20180095508A/ko not_active Application Discontinuation
- 2016-11-16 JP JP2018525722A patent/JP6923520B2/ja active Active
- 2016-11-16 BR BR112018010056-0A patent/BR112018010056B1/pt active IP Right Grant
-
2018
- 2018-05-16 ZA ZA2018/03250A patent/ZA201803250B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112018010056A2 (pt) | 2018-11-13 |
US20180370942A1 (en) | 2018-12-27 |
BR112018010056B1 (pt) | 2022-11-08 |
JP2018534312A (ja) | 2018-11-22 |
EP3170830A1 (en) | 2017-05-24 |
CA3005500A1 (en) | 2017-05-26 |
US10717718B2 (en) | 2020-07-21 |
WO2017085144A1 (en) | 2017-05-26 |
CN108431014B (zh) | 2021-08-10 |
EP3377507B1 (en) | 2021-12-08 |
AU2016358039A1 (en) | 2018-06-07 |
AU2016358039B2 (en) | 2020-10-15 |
KR20180095508A (ko) | 2018-08-27 |
JP6923520B2 (ja) | 2021-08-18 |
CN108431014A (zh) | 2018-08-21 |
EP3377507A1 (en) | 2018-09-26 |
ZA201803250B (en) | 2019-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201408539UA (en) | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | |
SG11201804373VA (en) | Compositions and methods for immunooncology | |
SG11201805838UA (en) | Macrocyclic mcl1 inhibitors for treating cancer | |
SG11201908640TA (en) | Pyrrolidinones and a process to prepare them | |
SG11201808582RA (en) | Pyrrolotriazine compounds as tam inhibitors | |
SG11201809714TA (en) | Piperidines as menin inhibitors | |
SG11201407534PA (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
SG11201807426WA (en) | Immunomodulators | |
SG11201805595TA (en) | Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid | |
SG11201804901WA (en) | Compounds for the treatment of cancer and inflammatory disease | |
SG11201408094YA (en) | Neprilysin inhibitors | |
SG11201808566WA (en) | Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide | |
SG11201407546QA (en) | Novel ring-substituted n-pyridinyl amides as kinase inhibitors | |
SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
SG11201810389XA (en) | New antibacterial compounds | |
SG11201909807TA (en) | Methods of manufacturing of niraparib | |
SG11201809830WA (en) | Selective reduction of cysteine-engineered antibodies | |
SG11201909083UA (en) | Piperidines as covalent menin inhibitors | |
SG11201808686VA (en) | Synthesis of indazoles | |
SG11201406945QA (en) | Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds | |
SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
SG11201804184SA (en) | New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 | |
SG11201805387RA (en) | Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists | |
SG11201407575PA (en) | 5-amino[1,4]thiazines as bace 1 inhibitors | |
SG11201901460UA (en) | Method for producing the crystalline form of modification a of calcobutrol |